Literature DB >> 28688030

From Pill to Condom, or Nothing at all: HIV Diagnosis and Discontinuation of Highly Effective Contraceptives Among Women in Northeast Brazil.

Bianca M Stifani1, Sarah MacCarthy2, Amy Nunn3, Nerys Benfield4, Inês Dourado5.   

Abstract

This is a cross-sectional study examining highly effective contraceptive (HEC) use among HIV-positive women in Salvador, Brazil. We used multivariate logistic regression to look for predictors of alternative contraceptive choices among women who discontinued HEC after HIV diagnosis. Of 914 participants surveyed, 38.5% of participants used HEC before but not after diagnosis. Of these, 65.9% used condoms alone; 19.3% used no protection; and 14.8% reported abstinence. Use of condoms alone was associated with a history of other sexually transmitted infections (AOR 2.18, 95% CI 1.09-4.66, p = 0.029). Abstinence was associated with recent diagnosis (AOR 8.48, 95% CI 2.20-32.64, p = 0.002). Using no method was associated with age below 25 (AOR 5.13, 95% CI 1.46-18.00, p = 0.011); income below minimum wage (AOR 2.54, 95% CI 1.31-4.92, p = 0.006); HIV-positive partner status (AOR 2.69, 95% CI 1.03-7.02, p = 0.043); and unknown partner status (AOR 2.90, 95% CI 1.04-8.05, p = 0.042). Improved contraceptive counseling is needed after HIV diagnosis. Continuation of HEC should be encouraged for women wishing to prevent pregnancy, and may increase contraceptive coverage among HIV-positive women.

Entities:  

Keywords:  Contraceptive methods; Contraceptive usage; HIV seropositivity; Women

Mesh:

Year:  2018        PMID: 28688030     DOI: 10.1007/s10461-017-1846-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  1 in total

1.  Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial.

Authors:  Margaret R Caplan; Raphael J Landovitz; Thesla Palanee-Phillips; Gonasagrie Nair; Felix Mhlanga; Jennifer E Balkus; Sharon A Riddler; Pamina M Gorbach
Journal:  AIDS Care       Date:  2019-02-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.